We demonstrated that LETM2 promotes tumor progression by activating the mTOR pathway, thereby inducing mitochondrial homeostasis and facilitating glycolysis, ultimately leading to accelerated proliferation of GC cells. Here, LETM2 is linked to neoplasm.